Skip to content

Issue 04-11-2011

Walgreens gets e-commerce edge with drugstore.com

Walgreen Co.’s $409 million purchase of drugstore.com, which followed the sale of its pharmacy benefits management division, underlines the chain’s rededication to retailing in all its forms. It also contrasts Walgreens with rival CVS Caremark Corp.

Medication adherence is in the spotlight

The overwhelming and underappreciated cost of medication nonadherence was highlighted last month in a supplement in The Washington Post. The chain drug industry was well represented in the 12-page report, assembled by MediaPlanet Publishing Inc. and subtitled “Fixing America’s Other Drug Problem.

CVS exec: Rx services just part of equation

Chain drug retailers need to expand their health care offerings beyond the pharmacy if they hope to meet the needs of their current and future customers, contends CVS Caremark Corp. senior vice president and chief marketing officer Rob Price. Speaking at SymphonyIRI Group Inc.

APhA, Cardinal team up to fight medication abuse

The Cardinal Health Foundation and the American Pharmacists Association (APhA) have formed a partnership to encourage pharmacists and student pharmacists to take an active role in preventing the abuse and misuse of prescription medications.

Business group honors Navarro

Navarro Discount Pharmacy has received the Top 100 Minority Business Award from the Greater Miami Chamber of Commerce. Navarro is the largest Hispanic-owned drug chain in the United States.

Walgreens, CVS are taking divergent paths

In the immediate aftermath of Walgreens’ announced purchase of drugstore.com, the burning questions of the moment in mass retailing are these: Is a drug store a retail outlet or a health care provider? Or can it be both? Clearly, Walgreens is buying drugstore.

CVS Caremark aims to heighten impact on Rx

When Larry Merlo became chief executive officer of CVS Caremark Corp. last month he made it clear that his top priority is to realize the full potential of the integrated pharmacy care model that has decisively shaped the evolution of the company in recent years.